Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Celltrion (068270 KP)
Watchlist
21
Analysis
Health Care
•
South Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
SillaJen Inc
•
29 Nov 2016 05:36
SillaJen IPO Part 5 - Revenue & Valuation Estimates with Pexa-Vec's First Commercialization Year
We need to examine the size of SillaJen's expected sales in 2020, which is the reference year for its entire valuation. With an assumption that...
Sanghyun Park
Follow
298 Views
Share
bullish
•
SillaJen Inc
•
26 Nov 2016 03:48
SillaJen IPO Part 4 - IPO Price & Post-IPO Risks
SillaJen IPO price was set at ₩15,000, the lowest end of the indicative price band, after conducting the demand survey from (Nov 23-24) the...
Sanghyun Park
Follow
288 Views
Share
bullish
•
SillaJen Inc
•
21 Nov 2016 13:33
SillaJen IPO Part 3 - Competitive Strengths of Product (Pexa-Vec)
* In Part 3 (as below), I summarized the competitive strengths of product (Pexa-Vec).SillaJen's Pexa-Vec is an advanced liver cancer treatment...
Sanghyun Park
Follow
252 Views
Share
bullish
•
Samsung Biologics
•
11 Nov 2016 06:05
Recap of Samsung BioLogics' First Trading Day - Foreign Institutions Net Purchased 1M Shares
Samsung BioLogics closed at ₩144,000 with 6.67% gain on its first trading day. It started with a relatively weak sentiment at the opening price of...
Sanghyun Park
Follow
200 Views
Share
bullish
•
Samsung Biologics
•
10 Nov 2016 06:20
Samsung BioLogics' First Trading Day - Blunders in Barron's Argument & Price Prediction
As reported by Barron's on Nov 5 ("Samsung BioLogics IPO: Too Expensive"), there are still some skeptical views on BioLogics' IPO valuation....
Sanghyun Park
Follow
235 Views
Share
First
Previous
84
85
86
87
88
89
90
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x